The ‘Real-Life’ Impact of Adding Bevacizumab to First-Line Therapy in Metastatic Colorectal Cancer Patients: A Large Israeli Retrospective Cohort Study
Acta Oncologica - United Kingdom
doi 10.3109/0284186x.2014.958532
Full Text
Open PDFAbstract
Available in full text
Date
October 28, 2014
Authors
Publisher
Informa UK Limited